Cita APA

Pan, C., Zhao, Y., Bian, Y., Shang, R., Wang, J., Xue, L., . . . Xu, F. (2018). Aldehyde dehydrogenase 2 Glu504Lys variant predicts a worse prognosis of acute coronary syndrome patients. J Cell Mol Med.

Citación estilo Chicago

Pan, Chang, et al. "Aldehyde Dehydrogenase 2 Glu504Lys Variant Predicts a Worse Prognosis of Acute Coronary Syndrome Patients." J Cell Mol Med 2018.

Cita MLA

Pan, Chang, et al. "Aldehyde Dehydrogenase 2 Glu504Lys Variant Predicts a Worse Prognosis of Acute Coronary Syndrome Patients." J Cell Mol Med 2018.